» Articles » PMID: 29205500

A Functional SNP in the 3'-UTR of TAP2 Gene Interacts with MicroRNA Hsa-miR-1270 to Suppress the Gene Expression

Overview
Date 2017 Dec 6
PMID 29205500
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The transporter associated with antigen processing 2 (TAP2) is involved in the development of multidrug resistance and the etiology of immunological diseases. In this study, we investigated whether the expression of TAP2 can be perturbed by single nucleotide polymorphisms (SNPs) located in 3'-untranslated region (3'-UTR) of the gene via interactions with microRNAs. Using a series of in silico assays, we selected the candidate microRNAs (miRNAs) with the potential to interact with functional SNPs of TAP2. The SNP rs241456-located in the 3'-UTR of TAP2-resides in a potential binding site for hsa-miR-1270 and hsa-miR-620. HEK 293 cells, from a human kidney cell line, were used to characterize the extent of binding of miRNAs to each polymorphic allele of the SNP by a luciferase reporter gene assay. RNA electrophoretic mobility shift assays were used to evaluate the interaction between the miRNAs and each allele sequence of the SNP. We found that hsa-miR-1270 inhibited luciferase activity by binding to the T allele of the SNP in an allele-specific manner. A negative correlation was also found between the expression of hsa-miR-1270 and the T allele of the SNP in kidney tissues. Our findings support the hypothesis that hsa-miR-1270 suppresses the production of TAP2 by binding to this SNP in the 3'-UTR of this gene. Environ. Mol. Mutagen. 59:134-143, 2018. © 2017 Wiley Periodicals, Inc.

Citing Articles

Sex-Biased CD3ζ 3'-UTR SNP Increased Incidence Risk in Aplastic Anemia.

Guo L, Zhang Y, Liu X, Xiao Y, Luo W, Fang S Int J Gen Med. 2024; 17:6343-6353.

PMID: 39720574 PMC: 11668313. DOI: 10.2147/IJGM.S489870.


Genetic Variants at PRKCG Splice and UTR Sites Promote Cancer Susceptibility by Disrupting Epigenetic and miRNA Regulatory Network.

Abid F, Khan K, Ashraf N, Badshah Y, Shabbir M, Trembley J J Cancer. 2024; 15(20):6644-6657.

PMID: 39668814 PMC: 11632988. DOI: 10.7150/jca.100911.


SNPs in 3'UTR miRNA Target Sequences Associated with Individual Drug Susceptibility.

Rykova E, Ershov N, Damarov I, Merkulova T Int J Mol Sci. 2022; 23(22).

PMID: 36430200 PMC: 9692299. DOI: 10.3390/ijms232213725.


Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma.

Youn B, Cheong H, Namgoong S, Kim L, Baek I, Kim J Mol Biol Rep. 2022; 49(11):10339-10346.

PMID: 36097105 DOI: 10.1007/s11033-022-07796-1.


Association of miRNA targetome variants in LAMC1 and GNB3 genes with colorectal cancer and obesity.

Gholami M, Zoughi M, Behboo R, Taslimi R, Kazemeini A, Bastami M Cancer Med. 2022; 11(21):3923-3938.

PMID: 35373932 PMC: 9636511. DOI: 10.1002/cam4.4713.


References
1.
Yu D, Green B, Tolleson W, Jin Y, Mei N, Guo Y . MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells. Biochem Pharmacol. 2015; 98(1):215-23. PMC: 5673105. DOI: 10.1016/j.bcp.2015.08.094. View

2.
Yang L, Price E, Chang C, Li Y, Huang Y, Guo L . Gene expression variability in human hepatic drug metabolizing enzymes and transporters. PLoS One. 2013; 8(4):e60368. PMC: 3634068. DOI: 10.1371/journal.pone.0060368. View

3.
De Iuliis F, Salerno G, Taglieri L, Scarpa S . Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review. Cancer Chemother Pharmacol. 2015; 76(4):679-90. DOI: 10.1007/s00280-015-2818-4. View

4.
Chen Y, Zeng L, Wang Y, Tolleson W, Knox B, Chen S . The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p. Biochem Pharmacol. 2017; 145:178-191. PMC: 5712447. DOI: 10.1016/j.bcp.2017.08.012. View

5.
Mika K, Lynch V . An Ancient Fecundability-Associated Polymorphism Switches a Repressor into an Enhancer of Endometrial TAP2 Expression. Am J Hum Genet. 2016; 99(5):1059-1071. PMC: 5097936. DOI: 10.1016/j.ajhg.2016.09.002. View